// App-Quantinova.ai

[AB0676] : NEUTROPHIL LYMPHOCYTE RATIO CAN BE A VALUABLE MARKER IN DEFINING DISEASE ACTIVITY IN PATIENTS WITH AS

Researchers

Presenter

  • Y. Pehlivan

Principal Investigators

  • B. N. COskun

  • M. F. Oksuz

  • E. Dalkilic

  • A. N. Tufan

Medical Centers

  • Rheumatology, Uludag University, School of Medicine, Bursa, Turkey,

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Rheumatoid arthritis

  • Scleroderma

  • Spondyloarthritis

  • Venous thrombosis

  • Inflammatory Arthritis

Biomarkers

  • Neutrophil lymphocyte ratio

  • C reactive protein

  • Estrogen receptor alpha

  • Tumor necrosis factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved